GLP Watchdog

Hers vs Synergy Rx

Hers has an open FDA warning letter dated September 9, 2025. Synergy Rx has none. On compounded semaglutide injection, the standing prices are within $1 a month of each other: $199 at Hers and $199 at Synergy Rx.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Hers / Synergy Rx

Hers logo

Hers

6.8/10

Synergy Rx logo

Synergy Rx

7.5/10

FDA warning letters
None on record
Pharmacy
Lowest standing price
$199/moCompounded semaglutide injection
$199/moCompounded semaglutide injection
States
All 50 states
All 50 states
Checked
Prices captured Record checked September 2026
Prices captured Record checked October 2026
Visit HersFull review
Visit Synergy RxFull review

Neither Hers nor Synergy Rx pays us. Links to them earn nothing. Scores: Hers 6.8, Synergy Rx 7.5. How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. Synergy Rx has none.

  2. 02

    Hers names three pharmacies. Synergy Rx names four pharmacies.

  3. 03

    On compounded semaglutide injection, the standing prices are within $1 a month of each other: $199 at Hers and $199 at Synergy Rx.

  4. 04

    Only Synergy Rx lists a price for compounded tirzepatide injection, brand-name semaglutide pen and compounded oral semaglutide.

  5. 05

    Hers states you can cancel at any time; Synergy Rx does not state its cancellation terms.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Hers

Synergy Rx

Compounded semaglutide injection

$199/mo

$2,388 a year

$199/mo

$2,388 a year

Brand-name tirzepatide pen

$299/mo

medication only, membership extra; not compared

$947/mo

$11,364 a year

Compounded tirzepatide injection
Not sold or not priced

$349/mo

$4,188 a year

Brand-name semaglutide pen
Not sold or not priced

$499/mo

$5,988 a year

Compounded oral semaglutide
Not sold or not priced

$299/mo

$3,588 a year

Compounded oral tirzepatide
Not sold or not priced

$399/mo

$4,788 a year

Price includes
Medication
Medication, clinician visits, shipping
Billed separately
Clinician visits, coaching
Not stated
Cancel any time
Yes, stated
Not stated
Minimum term
None
Not stated
Refunds
No refund guaranteed once the pharmacy has processed an order
Non-refundable, all sales final

Read off each seller’s own pages. Hers: September 28, 2026. Synergy Rx: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Hers

6.8/10
  • States you can cancel at any time
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

The case for Synergy Rx

7.5/10
  • No FDA warning letter on record
  • Sells compounded tirzepatide injection and brand-name semaglutide pen, which Hers does not price
  • Price includes clinician visits
Visit Synergy Rx

Scores

Hers 6.8 · Synergy Rx 7.5 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.0A
vs
B
9.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

3.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Hers vs Synergy Rx: questions

Hers has an open FDA warning letter dated September 9, 2025. Synergy Rx has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Hers names three pharmacies. Synergy Rx names four pharmacies. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Neither, by more than $1 a month. Hers charges $199 a month and Synergy Rx $199 a month.
Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order. Synergy Rx does not state its cancellation terms.
Neither Hers nor Synergy Rx pays us. Links to them earn nothing. Scores: Hers 6.8, Synergy Rx 7.5.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks